The impact on the field of implementation science by Regenstrief Institute Research Scientist Edward J. Miech, EdD, continues to grow.
Apr 8, 2022
0
3
Researchers have discovered in mice an additional use of globins as an intravenous drug that can delay liver fibrosis progression. Last year, the application of recombinant human cytoglobin (CYGB) as a protein therapeutic ...
Mar 23, 2022
0
17
Nonalcoholic fatty liver disease (NAFLD), a disease affecting approximately one-quarter of the world's adult population, reflects dysfunctional hepatic lipid metabolism. A better understanding of NAFLD heterogeneity and its ...
Mar 22, 2022
0
9
Exercise may help certain patients with nonalcoholic fatty liver disease (NAFLD) reduce their risk of developing blood clots, according to a new study by Penn State College of Medicine researchers. While diet and physical ...
Mar 1, 2022
0
5
When hepatitis C treatments fail, patients can face major health risks and the expense of a second therapy. Now, University of Florida Health researchers have developed algorithms that use artificial intelligence to accurately ...
Feb 17, 2022
0
14
New research from North Carolina State University has found that an imprinted gene associated with development of non-alcoholic fatty liver disease (NAFLD) is switched on in mice who nurse from mothers with metabolic syndrome, ...
Feb 7, 2022
0
38
In a recent article published in Hepatology, a group led by researchers at Osaka University investigated the molecular mechanisms that drive development of Intrahepatic cholangiocarcinoma (ICC)—a cancer which develops in ...
Jan 19, 2022
0
3
The urea cycle is responsible for removing nitrogenous waste produced from the breakdown of protein in the organism. If the OTC enzyme is missing in this cycle, ammonia accumulation rises to toxic levels. An OTC deficiency ...
Jan 17, 2022
0
11
Alcohol sales and consumption increased during the start of the COVID-19 pandemic, but the effect of the increase in consumption on population health is not fully understood. In new research published in Hepatology, a team ...
Dec 20, 2021
0
4
In recent years, tumor immunotherapy has emerged as a highly promising and much-touted oncological approach. It is based on using humanized antibodies called immune checkpoint inhibitors (ICIs) to block the cellular pathways ...
Dec 7, 2021
0
56
